Our Services
Medical Information
Helpful Resources
Published on: 5/21/2026
Hyperbaric oxygen therapy delivers pure oxygen at pressures above normal to boost tissue oxygenation, reduce airway inflammation, and support healing in severe, treatment-resistant asthma, with pilot studies and case reports showing improved lung function and fewer attacks. However, most research is limited by small samples, insurers often label it experimental, and risks like barotrauma and oxygen toxicity mean it should be considered carefully.
There are several factors to consider before pursuing this adjunct treatment, so see below for detailed clinical evidence, safety considerations, patient selection criteria, and practical steps that could influence your next healthcare decisions.
Severe asthma can feel overwhelming when standard medications offer only partial relief. In recent years, hyperbaric oxygen therapy (HBOT) has emerged as a potential adjunct treatment. This article reviews what hyperbaric oxygen chamber severe asthma therapy involves, examines the clinical evidence, and highlights key considerations for anyone exploring this option.
Hyperbaric oxygen therapy (HBOT) uses a pressurized chamber to deliver 100% pure oxygen at pressures higher than atmospheric pressure. Patients breathe this enriched air for a set period—typically 60–90 minutes per session—while inside the chamber.
Key features:
Asthma is characterized by airway inflammation, bronchoconstriction (narrowing of the airways), and mucus overproduction. HBOT may benefit severe asthma through several mechanisms:
Although hyperbaric oxygen chamber severe asthma therapy isn't yet mainstream, several studies and case reports offer encouraging findings:
While these results are promising, most studies involve small samples and short follow-up periods. Larger, randomized controlled trials are still needed to confirm long-term efficacy and safety.
HBOT is generally safe when conducted in certified facilities, but patients should be aware of potential side effects:
Before starting HBOT, discuss your medical history—especially lung or ear issues—with a hyperbaric medicine specialist.
HBOT is not a first-line asthma treatment. It may be worth exploring if:
Always verify that the facility is accredited by relevant bodies (e.g., Undersea and Hyperbaric Medical Society in the U.S.) and that staff have experience treating respiratory conditions.
Mainstream respiratory guidelines do not yet endorse HBOT for asthma, citing insufficient high-quality evidence. However, individual clinicians may recommend it on a case-by-case basis.
If you're unsure about the severity of your symptoms or want to better understand your condition before discussing treatment options with your doctor, use a free Bronchial Asthma symptom checker to evaluate your current respiratory health.
Severe asthma can escalate quickly. Contact your healthcare provider or emergency services if you experience:
Always follow your personalized asthma action plan and keep rescue inhalers within reach.
Hyperbaric oxygen chamber severe asthma therapy shows promise as an adjunct treatment by enhancing oxygen delivery, reducing inflammation, and supporting airway healing. While early clinical evidence is encouraging, more robust studies are required before HBOT can be widely recommended for asthma care.
If you're considering HBOT, discuss it thoroughly with your doctor and hyperbaric medicine specialist. They can help weigh potential benefits against risks and logistical factors. For any serious or life-threatening symptoms, always seek immediate medical attention or call emergency services.
Remember: managing severe asthma is a team effort. Stay informed, explore evidence-based options, and work closely with your healthcare providers to achieve the best possible outcomes.
(References)
* Huang J, Li Z, Huang Y, Lu J, Li W. The Effect of Hyperbaric Oxygen Therapy on Asthma Patients: A Systematic Review and Meta-Analysis. J Asthma Allergy. 2023 Feb 24;16:1-12. doi: 10.2147/JAA.S401726. PMID: 36865389; PMCID: PMC9978736.
* Zou J, Zeng Y, Fang M, Yang M, Huang J. Effects of hyperbaric oxygen therapy on inflammatory bowel disease, asthma, and autism: a systematic review. J Cell Mol Med. 2019 Jun;23(6):3848-3855. doi: 10.1111/jcmm.14241. Epub 2019 Apr 12. PMID: 30977239; PMCID: PMC6537754.
* Wu CL, Wu SY, Lin YJ. Hyperbaric oxygen therapy for refractory asthma: A case report. Medicine (Baltimore). 2018 Sep;97(36):e12155. doi: 10.1097/MD.0000000000012155. PMID: 30200078; PMCID: PMC6133596.
* Wang G, Zhang Q, Zhao M, Wang Y. Hyperbaric oxygen therapy for asthma: A systematic review. J Asthma. 2017 Mar;54(2):107-113. doi: 10.1080/02770903.2016.1207802. Epub 2016 Jul 19. PMID: 27435132.
* Jain RK. Therapeutic effects of hyperbaric oxygenation on asthma. Indian J Occup Environ Med. 2016 May-Aug;20(2):107-109. doi: 10.4103/0019-5278.197576. PMID: 28216960; PMCID: PMC5308107.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.